Data / New clinical trials / Brain Neoplasms
Brain Neoplasms trials: 242 new since Nov 2024
The full list. New Brain Neoplasms clinical trials: 242 rows for $12.10, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 7 rows a month. The new rows come each week by email, $19 a month.
Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, enrollment type, location countries and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.
For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/brain-neoplasms, and every list with its row count and price is at https://specstream.ai/data/lists.json.
Updated November 4, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).
242 clinical studies in Brain Neoplasms were first posted on ClinicalTrials.gov from November 25, 2024 to November 4, 2026; 25 have an industry sponsor and 193 are recruiting or about to. The newest, NCT07916831, was posted on November 4, 2026: Tissue Penetration of Paracetamol in Pediatric Intensive Care Patients (University Hospital, Ghent).
The request: Every new Brain Neoplasms clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.
- 242New trials
- 25Industry sponsored
- 193Recruiting or not yet
- November 4, 2026Latest posted
Newest trials
The newest 100 of 242, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.
| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
|---|---|---|---|---|---|---|---|---|---|
| November 4, 2026 | NCT07916831 | Tissue Penetration of Paracetamol in Pediatric Intensive Care Patients | University Hospital, Ghent | Observational | Completed | Pediatric Critical Illness, Brain Injuries, Traumatic, Brain Neoplasms, Intracranial Hypertension, Hydrocephalus... | 31 | Belgium | clinicaltrials.gov |
| November 4, 2026 | NCT07916389 | Molecularly Stratified Trial for Newly Diagnosed Infant-Type Hemispheric Glioma | St. Jude Children's Research Hospital | Phase 2 | Not yet recruiting | Infant-Type Hemispheric Glioma | 50 | United States | clinicaltrials.gov |
| November 3, 2026 | NCT07912190 | ePRO in Advanced Lung Cancer: Emotional Distress, Symptom Burden, Brain Metastasis | Qian Chu | Observational | Recruiting | Lung Cancer, Brain Metastasis, Patient Reported Outcome | 200 | China | clinicaltrials.gov |
| November 2, 2026 | NCT07909460 | Blood Brain Barrier Dysfunction in Glioma and Epileptogenesis | University College, London | Observational | Not yet recruiting | Epilepsy, Glioma | 56 | clinicaltrials.gov | |
| October 29, 2026 | NCT07904013 | Impact of a Radiologic and Immunologic Signature on Cerebral Efficacy of Treatments in Lung Cancers With Brain Metastasis | University Hospital, Bordeaux | Observational | Not yet recruiting | Carcinoma, Non-Small-Cell Lung, Brain Neoplasms, Neoplasm Metastasis | 38 | France | clinicaltrials.gov |
| October 29, 2026 | NCT07903051 | Lemborexant on Perioperative Sleep Quality in Patients With Brain Tumor Undergoing Surgery | Beijing Tiantan Hospital | Phase 2 | Not yet recruiting | Brain Neoplasms, Sleep Initiation and Maintenance Disorders | 112 | clinicaltrials.gov | |
| October 28, 2026 | NCT07901140 | Adverse Events During Physical Therapy in Neurocritical ICU Patients | Hospital H+ Queretaro | Observational | Active not recruiting | Critical Illness, Brain Injury, Stroke, Subarachnoid Hemorrhage, Brain Neoplasms, Orthostatic Intolerance | 47 | Mexico | clinicaltrials.gov |
| October 23, 2026 | NCT07893197 | Ceritinib Treatment for Recurrent Meningiomas | Kevin Petrecca | Phase 2 | Not yet recruiting | Recurrent Meningioma, Grade I and Grade II | 10 | Canada | clinicaltrials.gov |
| October 22, 2026 | NCT07888647 | IDH1-vac in Patients With Newly Diagnosed IDH1R132H-positive High-grade Astrocytomas | German Cancer Research Center | Phase 2 | Not yet recruiting | Astrocytoma, IDH-Mutant, Grade 3, Astrocytoma, IDH-Mutant, Grade 4 | 216 | Germany | clinicaltrials.gov |
| October 20, 2026 | NCT07883720 | EXercise-induced PhysioLogical Adaptations In Neurological Disorders | Brigham and Women's Hospital | Not applicable | Recruiting | Epilepsy, Functional Neurological Disorder, Mild Cognitive Impairment, Dementia, Parkinson Disease, Concussion, Brain... | 240 | United States | clinicaltrials.gov |
| October 9, 2026 | NCT07867886 | An Optimization Study Evaluating Safety and Efficacy of the Y-90 Glioblastoma (GBM) Device in Patients With Recurrent GBM | Boston Scientific Corporation | Not applicable | Not yet recruiting | Recurrent Glioblastoma | 30 | France, Germany, Netherlands, Spain | clinicaltrials.gov |
| October 1, 2026 | NCT07851636 | Ultra-Rapid Profiling and Drug Screening for Treatment Selection in Patients With Relapsed or Recurrent Rare Brain Tumors | Adriana Fonseca | Not applicable | Recruiting | Rare CNS Tumor, FOXR2-activated, BCOR ITD Sarcoma, CNS Sarcoma, PLAG-altered Tumors, Mesenchymal Tumor | 20 | United States | clinicaltrials.gov |
| September 21, 2026 | NCT07831772 | REMIND Maintenance Radiotherapy for Newly Diagnosed Glioblastoma | University of Minnesota | Not applicable | Recruiting | Glioblastoma, Newly Diagnosed Glioblastoma, Brain Tumor | 4 | United States | clinicaltrials.gov |
| September 18, 2026 | NCT07827001 | PilotStudyAssessSafeActiveSurveillancApproachLocalThe Pa w/BrainMetsUndergoinCNSPenetratSystemicThe | University of California, Irvine | Observational | Recruiting | Brain Cancer, Brain Cancer Metastatic, Nervous System Cancer, CNS Cancer | 12 | United States | clinicaltrials.gov |
| September 18, 2026 | NCT07826949 | A Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma. | Nicholas Butowski | Phase 1 | Not yet recruiting | Recurrent High-Grade Gliomas, Brain Neoplasm, Glioma | 6 | United States | clinicaltrials.gov |
| September 17, 2026 | NCT07823985 | Preoperative Embolization for Highly Vascular Brain Tumors | Assiut University | Not applicable | Not yet recruiting | Brain Neoplasms, Meningioma, Hemangioblastoma, Brain Metastases | 55 | clinicaltrials.gov | |
| September 10, 2026 | NCT07813741 | Susceptibility-Weighted Imaging in Preoperative Grading of Cerebral Gliomas | Assiut University | Observational | Not yet recruiting | Glioma, Brain Neoplasms, Cerebral Glioma | 90 | clinicaltrials.gov | |
| September 8, 2026 | NCT07805876 | The Effect of Ciprofol Versus Propofol Anesthesia on Postoperative Neurological Complications | Beijing Tiantan Hospital | Not applicable | Not yet recruiting | Intracranial Tumors | 434 | China | clinicaltrials.gov |
| September 4, 2026 | NCT07805096 | Efficacy of a Smart Holistic Health Care Platform Intervention on Cancer Children and Parents' Bio-Psycho-Social and Spiritual Health | National Defense Medical University, Taiwan | Not applicable | Recruiting | Leukemia (Both ALL and AML), Brain Tumors | 120 | Taiwan | clinicaltrials.gov |
| September 2, 2026 | NCT07799623 | Ciprofol, Propofol and Sevoflurane for Postoperative Delirium in Elderly Brain Tumor Patients | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Not applicable | Not yet recruiting | Brain Neoplasms, Delirium - Postoperative | 381 | China | clinicaltrials.gov |
| September 1, 2026 | NCT07797660 | A Study for Postoperative Delirium in Older Patients With Intracranial Tumors | Beijing Tiantan Hospital | Observational | Not yet recruiting | Delirium, Brain Tumor | 164 | China | clinicaltrials.gov |
| August 25, 2026 | NCT07786311 | University of Kentucky Markey Cancer Center Neuro-Oncology Multi-Disciplinary Tumor Board Protocol for the Treatment of Advanced Brain... | John L. Villano, MD, PhD | Not applicable | Not yet recruiting | Brain Metastases | 125 | clinicaltrials.gov | |
| August 19, 2026 | NCT07773454 | Study of Zanzalintinib in Children and Adolescents With Relapsed or Refractory Solid Tumors | Exelixis | Phase 1 | Not yet recruiting | Cancer, Pediatric Cancer | 18 | clinicaltrials.gov | |
| August 19, 2026 | NCT07772323 | Bedside Cranial Ultrasound for Risk-Stratified Imaging in Pediatric Acute Brain Injury | Virginia Commonwealth University | Observational | Not yet recruiting | Acute Brain Injury, Traumatic Brain Injury, Intracranial Hemorrhage, Hydrocephalus, Stroke, Brain Neoplasm... | 220 | United States | clinicaltrials.gov |
| August 17, 2026 | NCT07769099 | Musical Training: Promoting Brain Function in Children Who Have Survived Brain Tumours | The Hong Kong Polytechnic University | Not applicable | Not yet recruiting | Cancer Childhood, Brain Tumor | 236 | Hong Kong | clinicaltrials.gov |
| August 7, 2026 | NCT07751744 | Phase 1/2 Study Evaluating the Safety, PK/PD, and Clinical Activity of Oral JBI-778 in Patients With Brain Metastases, Leptomeningeal... | Jubilant Therapeutics Inc. | Phase 1/2 | Not yet recruiting | Brain Metastases From Solid Tumors, Leptomeningeal Disease, High Grade Glioma (HGG), Glioblastoma (GBM) | 113 | clinicaltrials.gov | |
| July 31, 2026 | NCT07740239 | A COhort Study on Factors Leading to Vulnerability in Adult Patients With Serious Medical cOnditionS: the COSMOS-I Trial | Tampere University Hospital | Observational | Recruiting | Pelvic Fracture, Prostate Cancer, Lung Cancer, Brain Metastasis, Chronic Subdural Hematoma | 2,050 | Finland | clinicaltrials.gov |
| July 31, 2026 | NCT07739017 | OLIG2 Inhibitor CT-179 for Recurrent and Newly-diagnosed Glioblastoma | Olivia Newton-John Cancer Research Institute | Phase 1 | Not yet recruiting | Recurrent Glioblastoma, Newly Diagnosed MGMT Unmethylated Glioblastoma | 54 | Australia | clinicaltrials.gov |
| July 29, 2026 | NCT07733674 | Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma... | Radiomedix, Inc. | Phase 1 | Recruiting | Glioblastoma Multiforme (GBM), Pancreatic Ductal Adenocarcinoma (PDAC) | 20 | United States | clinicaltrials.gov |
| July 28, 2026 | NCT07732140 | Listen Aphasia Pilot Study | Dana-Farber Cancer Institute | Not applicable | Not yet recruiting | Aphasia, Malignant Brain Tumor | 80 | United States | clinicaltrials.gov |
| July 21, 2026 | NCT07717827 | Connectome-guided Onco-functional Resection With Tractography-Extended Neuronavigation in Brain Tumor Surgery | ARNAS Civico Di Cristina Benfratelli Hospital | Observational | Recruiting | Brain (Nervous System) Cancers, Glioma, Brain Metastasases, Brain Connectivity | 400 | Italy | clinicaltrials.gov |
| July 21, 2026 | NCT07716579 | Assessment of Endocrine and Metabolic Late Effects After Childhood Brain Tumor Treatment | Institute of Oncology Ljubljana | Not applicable | Completed | Brain Neoplasms, Endocrine System Diseases, Metabolic Diseases | 12 | Slovenia | clinicaltrials.gov |
| July 21, 2026 | NCT07716124 | Use of AlignRT System During Stereotactic Radiosurgery | Institute of Oncology Ljubljana | Not applicable | Completed | Brain Metastases | 20 | Slovenia | clinicaltrials.gov |
| July 17, 2026 | NCT07712198 | Al Prediction of Sarcopenia Risk in Neurocritical ICU Patients | Trabzon Kanuni Education and Research Hospital | Observational | Completed | Intracerebral Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, Epidural Hematoma, Ischemic Stroke, Brain... | 72 | Turkey (Türkiye) | clinicaltrials.gov |
| July 17, 2026 | NCT07710131 | Neurocognitive Assessment CNSL and LGG | Dana-Farber Cancer Institute | Not applicable | Not yet recruiting | PCNSL, Brain Tumor, Cognitive Dysfunction, IDH Mutation, Low-grade Glioma | 36 | clinicaltrials.gov | |
| July 14, 2026 | NCT07703761 | AI-driven Processing and Analysis of Glioma Imaging Data | Università degli Studi di Trento | Observational | Recruiting | Glioma, Glioma (Diagnosis) | 700 | Italy | clinicaltrials.gov |
| July 13, 2026 | NCT07699172 | EEG-Guided Cognitive Function Preservation in Patients With Brain Tumors | Bo Wang | Not applicable | Not yet recruiting | Glioma, Brain Neoplasm, Brain Tumor Adult | 10 | China | clinicaltrials.gov |
| July 8, 2026 | NCT07691255 | MELanoma Brain Metastasis Treated With CYberknife | European Institute of Oncology | Observational | Recruiting | Melanoma (Skin Cancer) | 50 | Italy | clinicaltrials.gov |
| July 8, 2026 | NCT07689721 | ctDNA-Guided Intraventricular Therapy for CNS Malignancies | Alireza Mansouri | Not applicable | Not yet recruiting | Leptomeningeal Disease, Glioblastoma, Brain Metastases, Non-Small Cell Lung Cancer, Breast Cancer | 77 | clinicaltrials.gov | |
| July 7, 2026 | NCT07688356 | Belvarafenib for CNS Efficacy in Patients With BRAF-Altered Solid Tumors | Samsung Medical Center | Phase 2 | Recruiting | Primary Brain Tumor, Metastatic Brain Tumor | 30 | South Korea | clinicaltrials.gov |
| July 7, 2026 | NCT07687277 | 3D-ASL and TDD-MRI for True Progression and Pseudoprogression After Glioma Surgery | Lanzhou University Second Hospital | Observational | Active not recruiting | Glioma, Brain Neoplasms | 75 | China | clinicaltrials.gov |
| July 6, 2026 | NCT07685301 | Development and Validation of an AI Foundation Model for CNS Tumor Classification | Huashan Hospital | Observational | Not yet recruiting | Brain Tumors, Central Nervous System Neoplasms | 20,000 | clinicaltrials.gov | |
| July 2, 2026 | NCT07680439 | Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG). | BrainChild Bio, Inc | Phase 2 | Recruiting | Diffuse Intrinsic Pontine Glioma, DIPG, Brain Tumor, CNS Tumor, Central Nervous System Tumor, Pediatric Cancer, Adult... | 75 | United States | clinicaltrials.gov |
| June 30, 2026 | NCT07675070 | Safety and Effectiveness Evaluation of Temozolomide (Amitzo, NanoAlvand) in Patients With Grade III and IV Glioma Tumors | NanoAlvand | Observational | Recruiting | Brain Tumor, Grade III Glioma, Grade IV Glioma | 100 | Iran | clinicaltrials.gov |
| June 29, 2026 | NCT07673705 | GliomaAI-Oligo: MRI-Based Detection of IDH Mutant Oligodendroglioma | Deep Learning Institute of Radiological Sciences | Observational | Completed | Glioma, Glioma (Diagnosis), Oligodendroglioma, 1p19q Codeletion, IDH-mutant Glioma (Oligodendroglioma, Astrocytoma) | 1,372 | India | clinicaltrials.gov |
| June 29, 2026 | NCT07673692 | GliomaAI-GBM: MRI-Based Detection of IDH Wildtype Glioblastoma | Deep Learning Institute of Radiological Sciences | Observational | Completed | Glioma, Glioma (Diagnosis), Glioblastom WHO Grade 4, IDH Wildtype Glioblastoma | 1,372 | India | clinicaltrials.gov |
| June 29, 2026 | NCT07673679 | GliomaAI-Astro4: MRI-Based Detection of IDH Mutant Astrocytoma Grade 4 | Deep Learning Institute of Radiological Sciences | Observational | Completed | Glioma, Glioma (Diagnosis), Astrocytoma, Astrocytoma, Grade IV, Astrocytoma, IDH-Mutant, Grade 4 | 1,372 | India | clinicaltrials.gov |
| June 29, 2026 | NCT07673666 | GliomaAI-Astro23: MRI-Based Detection of IDH Mutant Astrocytoma (Grade 2 and 3) | Deep Learning Institute of Radiological Sciences | Observational | Completed | Glioma, Glioma (Diagnosis), Astrocytoma, Astrocytoma of Brain, Astrocytoma, Grade II, Astrocytoma, IDH-Mutant, Grade 2... | 1,372 | India | clinicaltrials.gov |
| June 26, 2026 | NCT07670455 | Brain Radiotherapy Imaging for High-grade Glioma Using Hypoxia Targeting Through Oxygen-Enhanced Response | The Leeds Teaching Hospitals NHS Trust | Not applicable | Not yet recruiting | High Grade Gliomas, Hypoxia Brain, Glioblastoma (GBM), Brain Neoplasms, Adult | 25 | clinicaltrials.gov | |
| June 24, 2026 | NCT07664254 | GliomaAI-MG: MRI-Based Detection of Molecular Glioblastoma | Deep Learning Institute of Radiological Sciences | Observational | Completed | Glioma, Glioma (Diagnosis), Glioblastom WHO Grade 4 | 1,372 | India | clinicaltrials.gov |
| June 24, 2026 | NCT07664176 | NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors | Children's National Research Institute | Phase 1 | Recruiting | Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma, High Grade Gliomas, Medulloblastoma Recurrent, Ependymoma... | 30 | United States | clinicaltrials.gov |
| June 18, 2026 | NCT07657403 | CONNEctome-guided Navigation for Eloquent-area Tumor Surgery Trial | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Not applicable | Recruiting | Brain Neoplasms, Eloquent Area Brain Tumors | 200 | China | clinicaltrials.gov |
| June 18, 2026 | NCT07656103 | QH101 Cell Injection in Patients With Brain, Brain (Spinal) Meninges, and Spinal Cord Metastatic Malignant Solid Tumors | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Early phase 1 | Not yet recruiting | Brain Metastasis, Meningeal Metastasis, Spinal Cord Metastasis | 7 | China | clinicaltrials.gov |
| June 18, 2026 | NCT07655583 | OBSERVE: A Pilot Study Of Omission Of Brain Metastasis Stereotactic Radiosurgery Following Resection With CNS-Active Systemic Therapy | M.D. Anderson Cancer Center | Phase 1 | Recruiting | Brain Metastasis, Stereotactic Radiosurgery, Resection, Systemic Therapy | 20 | United States | clinicaltrials.gov |
| June 12, 2026 | NCT07646041 | Annual Brain MRI Surveillance for Detection of Brain Metastasis in Patients With Lung Cancer | Samsung Medical Center | Observational | Completed | Lung Cancer, Brain Metastasases, MRI, Surveillance | 229,323 | clinicaltrials.gov | |
| June 9, 2026 | NCT07635329 | Home-based Vision Rehabilitation Guided by Brain Imaging | Georgetown University | Not applicable | Recruiting | Visual Field Defect, Stroke, Hemianopia Homonymous, Quadrantanopia, Cortical Blindness, Visual Field Defect... | 100 | United States | clinicaltrials.gov |
| June 8, 2026 | NCT07632092 | Early [18F]-FDG PET Dynamic Analysis in Brain Metastases After Radiotherapy. | Centre Hospitalier Universitaire, Amiens | Observational | Recruiting | Short Time Examination, Brain Metastases, Radiation Necrosis | 50 | France | clinicaltrials.gov |
| June 8, 2026 | NCT07631611 | Organ-Specific Differences in Immunotherapy Response Among Metastatic Cancer Patients | Wenlong Zhong, MD | Observational | Completed | Solid Tumors, Metastatic Cancer to Liver, Metastatic Cancer to the Bone, Metastatic Cancer to the Lung, Brain... | 938 | China | clinicaltrials.gov |
| June 8, 2026 | NCT07631338 | Low-grade Gliomas in Argentina: Incidence, Survival, and Therapeutic Strategies | Hospital Italiano de Buenos Aires | Observational | Recruiting | Low-grade Glioma | 40 | Argentina | clinicaltrials.gov |
| June 5, 2026 | NCT07630753 | Effect of Pregabalin on Optic Nerve Sheath Diameter in Craniotomy Patients. | Benha University | Not applicable | Active not recruiting | Pregabalin, Optic Nerve Sheath Diameter Measurement, Intracranial Pressure Changes | 100 | Egypt | clinicaltrials.gov |
| June 5, 2026 | NCT07628647 | Living Well With Brain Cancer: A Group-Based Intervention to Promote Whole-Person Well-Being | University of Colorado, Denver | Not applicable | Recruiting | Brain Cancer | 64 | United States | clinicaltrials.gov |
| June 3, 2026 | NCT07623577 | Sac-TMT Combined With Bevacizumab in TNBC With Brain Metastases | Fudan University | Phase 2 | Recruiting | TNBC, Brain Metastasis | 24 | China | clinicaltrials.gov |
| June 2, 2026 | NCT07620470 | Spectral Precise Image Study for Brain Tumors | Philips Clinical & Medical Affairs Global | Observational | Recruiting | Brain Tumors | 120 | China | clinicaltrials.gov |
| June 2, 2026 | NCT07619599 | A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer... | City of Hope Medical Center | Phase 1 | Recruiting | Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Neoplasm in the Brain, Oligoprogressive Lung Non-Small... | 6 | United States | clinicaltrials.gov |
| June 1, 2026 | NCT07617168 | The Effect of Education Brain Tumors | Istanbul University - Cerrahpasa | Not applicable | Recruiting | Primary Brain Neoplasms | 72 | Turkey (Türkiye) | clinicaltrials.gov |
| May 20, 2026 | NCT07599917 | Diagnostic Performance and Quantitative Analysis of [18F]FET PET in Brain Tumours | IRCCS San Raffaele | Observational | Not yet recruiting | Brain Tumors | 69 | clinicaltrials.gov | |
| May 19, 2026 | NCT07595666 | Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region. | prof. dr. Koen Van Laere | Not applicable | Enrolling by invitation | Dementia, Movement Disorders, ALS - Amyotrophic Lateral Sclerosis, Epilepsy, Brain Tumors, Pituitary Adenoma, Large... | 1,600 | Belgium | clinicaltrials.gov |
| May 15, 2026 | NCT07590726 | PIRe 2.0: A Stepped-Care Model for Involving Relatives Across Sectors | Copenhagen University Hospital, Rigshospitalet | Not applicable | Not yet recruiting | Brain Injuries, Acute, Brain Tumor Adult, Brain (Nervous System) Cancers, Traumatic Brain Injuries, Glioblastom WHO... | 160 | Denmark | clinicaltrials.gov |
| May 6, 2026 | NCT07570485 | Feasibility Assessment of Adapted Physical Activity in Patients Treated for a Brain Tumor | Center Eugene Marquis | Not applicable | Recruiting | Brain Tumor Adult | 90 | France | clinicaltrials.gov |
| May 6, 2026 | NCT07569263 | IL-8 Receptor Modified Patient-Derived Activated CD70 CAR T Cell Therapy in Adults With Brain Metastases | University of Florida | Phase 1 | Recruiting | Brain Metastases | 12 | United States | clinicaltrials.gov |
| May 6, 2026 | NCT07569042 | A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma | Novelwise Pharmaceutical Corporation | Phase 1/2 | Recruiting | Malignant Neoplasm of Brain | 15 | Taiwan | clinicaltrials.gov |
| April 30, 2026 | NCT07558473 | Measuring Brain Changes Following Cognitive Intervention in Pediatric Patients With Brain Tumors | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | Not applicable | Not yet recruiting | Brain Tumor, Pediatric | 300 | United States | clinicaltrials.gov |
| April 30, 2026 | NCT07558395 | Effectiveness of a Visual Telerehabilitation Program on Visual Perception in Children, Adolescents and Young Adults With Hemianopsia... | Institut National de la Santé Et de la Recherche Médicale, France | Not applicable | Not yet recruiting | Hemianopsia, Virtual Reality, Visual Rehabilitation, Pediatric Brain Tumor | 120 | Austria, Denmark, France, Italy, Netherlands, Spain, United Kingdom | clinicaltrials.gov |
| April 27, 2026 | NCT07552233 | NK Cell Therapy for Malignant Solid Brain Tumors | Peking University Third Hospital | Not applicable | Recruiting | Malignant Solid Brain Tumors, Glioblastoma (GBM), Glioblastoma Multiforme (GBM), Brain Metastasis, Malignant Meningioma | 27 | China | clinicaltrials.gov |
| April 21, 2026 | NCT07542288 | Comparison of the Therapeutic Effects of Methylprednisolone and Dexamethasone on Peritumoral Edema During Radiotherapy for Brain Metastases: | The Second Affiliated Hospital of Hainan Medical University | Phase 2/3 | Not yet recruiting | Brain Metastases From Solid Tumors | 400 | China | clinicaltrials.gov |
| April 20, 2026 | NCT07539753 | Brain Radiotherapy Combined With Dalpiciclib and Endocrine Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer With Brain Metastases | Nanfang Hospital, Southern Medical University | Phase 2 | Not yet recruiting | Breast Cancer, Brain Metastases, HR+/HER2- Breast Cancer | 46 | China | clinicaltrials.gov |
| April 15, 2026 | NCT07530536 | rTMS for Postoperative Brain Tumor Patients | Brian J.Gill | Not applicable | Recruiting | Brain Tumors, Transcranial Magnetic Stimulation, Motor Deficit, Quality of Life | 6 | United States | clinicaltrials.gov |
| April 9, 2026 | NCT07520370 | Effect of Perioperative Ulinastatin on Postoperative Stroke in Patients With Brain Tumor | Beijing Tiantan Hospital | Not applicable | Not yet recruiting | Brain Tumor, Stroke, Ulinastatin, Perioperative Anti-inflammatory Therapy | 1,370 | clinicaltrials.gov | |
| April 6, 2026 | NCT07512154 | Precision Radiotherapy Enabled by Molecular MRI | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Not applicable | Recruiting | Brain Cancer | 20 | United States | clinicaltrials.gov |
| April 6, 2026 | NCT07511933 | Novel Ga68-PSMA PET/CT-tracer to Differentiate Between Radiation Necrosis and Tumor Progression in Brain Metastases | The Netherlands Cancer Institute | Not applicable | Recruiting | Brain Metastases From Non-small Cell Lung Cancer (NSCLC), Brain Metastases From Melanoma, Brain Metastases From Breast... | 100 | Netherlands | clinicaltrials.gov |
| April 1, 2026 | NCT07505979 | SMART Trial: Cognitive Sparing Brain Radiotherapy for Multiple Brain Metastases | National Taiwan University Hospital | Phase 2 | Not yet recruiting | Brain Metastases From Solid Tumors | 90 | clinicaltrials.gov | |
| March 30, 2026 | NCT07499141 | Use of Fluorescence in Gliomas | Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria | Observational | Completed | High Grade Glioma, Glioblastoma, Brain Neoplasms | 41 | Italy | clinicaltrials.gov |
| March 27, 2026 | NCT07496073 | A Phase I, Single-arm, Open-label Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of CHT101 Cell Infusion... | Tianjin Medical University Cancer Institute and Hospital | Phase 1 | Not yet recruiting | Brain (Nervous System) Cancers | 30 | clinicaltrials.gov | |
| March 25, 2026 | NCT07493447 | Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures | Eben Rosenthal | Early phase 1 | Recruiting | Meningioma, Glioblastoma, Acoustic Neuroma, Brain Cancer, Pituitary Adenoma | 30 | United States | clinicaltrials.gov |
| March 25, 2026 | NCT07492680 | A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic... | Bristol-Myers Squibb | Phase 2 | Recruiting | Solid Tumors | 254 | Belgium, Canada, China, France, Germany, Hong Kong, Ireland, Italy, Japan... | clinicaltrials.gov |
| March 24, 2026 | NCT07491211 | Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases | Fudan University | Observational | Active not recruiting | NSCLC (Advanced Non-small Cell Lung Cancer), Brain Metastases From Non-small Cell Lung Cancer (NSCLC), Osimertinib... | 300 | China | clinicaltrials.gov |
| March 19, 2026 | NCT07481786 | Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases | Sun Yat-sen University | Phase 3 | Recruiting | Lung Adenocarcinoma, Brain Metastases, Radiotherapy, Intensity-Modulated, Bevacizumab, Whole-Brain Radiotherapy | 220 | China | clinicaltrials.gov |
| March 13, 2026 | NCT07470606 | Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain | The University of Texas Health Science Center at San Antonio | Phase 2 | Recruiting | Brain Tumor | 108 | United States | clinicaltrials.gov |
| March 12, 2026 | NCT07467109 | A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers | M.D. Anderson Cancer Center | Observational | Recruiting | Intracranial Venous Blood, Brain Cancers, Liquid Biopsy, Evaluate the Safety | 20 | United States | clinicaltrials.gov |
| March 11, 2026 | NCT07464470 | Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Gastroesophageal Cancers | Blokhin's Russian Cancer Research Center | Observational | Recruiting | Gastric Cancer, Esophageal Cancer, Brain Metastases | 30 | Russia | clinicaltrials.gov |
| March 10, 2026 | NCT07462507 | Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1 | Washington University School of Medicine | Phase 2 | Recruiting | Central Nervous System Cancer, Brain Metastases | 104 | United States | clinicaltrials.gov |
| March 9, 2026 | NCT07458113 | Sac-TMT for Active TNBC Brain Metastases | Yale University | Phase 2 | Not yet recruiting | Metastatic Triple Negative Breast Cancers | 20 | United States | clinicaltrials.gov |
| March 6, 2026 | NCT07454668 | Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases | Baptist Health South Florida | Phase 1 | Not yet recruiting | Breast Cancer, HER2-positive Breast Cancer, Brain Metastases, Cancer, Cancer Metastatic | 20 | United States | clinicaltrials.gov |
| March 4, 2026 | NCT07449481 | A Phase II Clinical Study of Utidelone and Bevacizumab With or Without Etoposide in Patients With Brain Metastases From Malignant Solid... | Tianjin Medical University Cancer Institute and Hospital | Phase 2 | Withdrawn | Malignant Solid Tumor, Brain Metastasis | 0 | clinicaltrials.gov | |
| March 4, 2026 | NCT07448662 | Local Treatment Strategies for Brain Metastases of Colorectal Cancer | Blokhin's Russian Cancer Research Center | Observational | Active not recruiting | Colorectal Cancer, Brain Metastases, Adult | 700 | Belarus, Russia | clinicaltrials.gov |
| March 4, 2026 | NCT07448493 | Local Treatment Strategies for Brain Metastases of Gastric and Esophageal Cancer | Blokhin's Russian Cancer Research Center | Observational | Active not recruiting | Gastric Cancer, Esophageal Cancer, Brain Metastases | 230 | Belarus, Russia | clinicaltrials.gov |
| March 3, 2026 | NCT07446842 | Construction of AI Model for Precision Imaging Diagnosis of Cranial Diseases | Tongji Hospital | Observational | Recruiting | Cranial Diseases (e.g., Brain Tumors, Stroke, Neurodegenerative Disorders) | 1,000 | China | clinicaltrials.gov |
| February 27, 2026 | NCT07439172 | Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma. | Cooper Norcross Health | Phase 2 | Recruiting | High Grade Gliomas, Glioblastoma, Astrocytoma, Oligodendroglioma | 70 | United States | clinicaltrials.gov |
| February 27, 2026 | NCT07437820 | Study Comparing Neoadjuvant Versus Adjuvant Stereotactic Radiotherapy of Brain Metastases | GCS Ramsay Santé pour l'Enseignement et la Recherche | Not applicable | Not yet recruiting | Brain Metastases, Adult | 68 | France | clinicaltrials.gov |
| February 24, 2026 | NCT07428616 | A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma | Exelixis | Phase 2 | Recruiting | Meningioma | 100 | United States | clinicaltrials.gov |
Sponsors posting most
| Sponsor | New trials | Latest |
|---|---|---|
| Beijing Tiantan Hospital | 5 | October 29, 2026 |
| Deep Learning Institute of Radiological Sciences | 5 | June 29, 2026 |
| M.D. Anderson Cancer Center | 4 | June 18, 2026 |
| Fudan University | 4 | June 3, 2026 |
| Tianjin Medical University Cancer Institute and Hospital | 4 | March 27, 2026 |
| Tata Memorial Centre | 4 | January 14, 2026 |
| Virginia Commonwealth University | 3 | August 19, 2026 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 3 | June 18, 2026 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 3 | April 6, 2026 |
| Blokhin's Russian Cancer Research Center | 3 | March 11, 2026 |
| Mayo Clinic | 3 | September 16, 2025 |
| University College, London | 2 | November 2, 2026 |
| University Hospital, Bordeaux | 2 | October 29, 2026 |
| Assiut University | 2 | September 17, 2026 |
| Exelixis | 2 | August 19, 2026 |
| Dana-Farber Cancer Institute | 2 | July 28, 2026 |
| Institute of Oncology Ljubljana | 2 | July 21, 2026 |
| Samsung Medical Center | 2 | July 7, 2026 |
| Georgetown University | 2 | June 9, 2026 |
| University of Colorado, Denver | 2 | June 5, 2026 |
By phase
| Phase | New trials | Latest |
|---|---|---|
| Not applicable | 80 | October 20, 2026 |
| Observational | 69 | November 4, 2026 |
| Phase 2 | 43 | November 4, 2026 |
| Phase 1 | 26 | September 18, 2026 |
| Phase 3 | 8 | March 19, 2026 |
| Phase 1/2 | 7 | August 7, 2026 |
| Early phase 1 | 7 | June 18, 2026 |
| Phase 2/3 | 1 | April 21, 2026 |
| Phase 4 | 1 | November 5, 2025 |
By country
| Country | New trials | Latest |
|---|---|---|
| United States | 85 | November 4, 2026 |
| China | 36 | November 3, 2026 |
| France | 13 | October 29, 2026 |
| Italy | 10 | July 21, 2026 |
| Netherlands | 9 | October 9, 2026 |
| India | 9 | June 29, 2026 |
| Belgium | 7 | November 4, 2026 |
| Canada | 5 | October 23, 2026 |
| Germany | 5 | October 22, 2026 |
| Spain | 4 | October 9, 2026 |
| Taiwan | 4 | September 4, 2026 |
| Australia | 4 | July 31, 2026 |
| Denmark | 4 | May 15, 2026 |
| Hong Kong | 3 | August 17, 2026 |
| Turkey (Türkiye) | 3 | July 17, 2026 |
| Egypt | 3 | June 5, 2026 |
| United Kingdom | 3 | April 30, 2026 |
| Russia | 3 | March 11, 2026 |
| Slovenia | 2 | July 21, 2026 |
| South Korea | 2 | July 7, 2026 |
| Austria | 2 | April 30, 2026 |
| Ireland | 2 | March 25, 2026 |
| Belarus | 2 | March 4, 2026 |
| Poland | 2 | February 17, 2026 |
| Sweden | 2 | February 2, 2026 |
Where the register publishes
U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.